A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

This Italian observational study is collecting real-world data on adults with severe uncontrolled eosinophilic asthma (a type of asthma driven by high levels of a white blood cell called eosinophils) who are starting treatment with benralizumab, an approved biologic injection. **You may be eligible if...** - You are 18 or older and have been diagnosed with severe uncontrolled eosinophilic asthma - Your doctor has prescribed benralizumab as part of your regular care (within 7 days before or after enrollment) - You are starting benralizumab for the first time (or have not received it in the past 12 months) **You may NOT be eligible if...** - You have received benralizumab in the past 12 months - You are currently in or recently completed another clinical trial - You have a contraindication to benralizumab - You are pregnant or breastfeeding - You have been recently treated with other biologic asthma medications without an adequate washout period Talk to your doctor to see if this trial is right for you.